Home Quinolines 34846-64-5
34846-64-5,MFCD00006766
Catalog No.:AA003JTO

34846-64-5 | 3-Quinolinecarbonitrile

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$6.00   $4.00
- +
250mg
97%
in stock  
$8.00   $6.00
- +
2g
95%
in stock  
$30.00   $21.00
- +
5g
95%
in stock  
$70.00   $49.00
- +
10g
95%
in stock  
$138.00   $96.00
- +
15g
95%
in stock  
$203.00   $142.00
- +
25g
95%
in stock  
$336.00   $235.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA003JTO
Chemical Name:
3-Quinolinecarbonitrile
CAS Number:
34846-64-5
Molecular Formula:
C10H6N2
Molecular Weight:
154.1680
MDL Number:
MFCD00006766
SMILES:
N#Cc1cnc2c(c1)cccc2
NSC Number:
44644
Properties
Properties
 
BP:
323.7°C at 760 mmHg  
Form:
Solid  
MP:
108-110 °C  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
203  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
XLogP3:
1.6  

Literature

Title: Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry 20120801

Title: Development of a new epidermal growth factor receptor positron emission tomography imaging agent based on the 3-cyanoquinoline core: synthesis and biological evaluation.

Journal: Bioorganic & medicinal chemistry 20100915

Title: 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20090901

Title: Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.

Journal: Bioorganic & medicinal chemistry letters 20090101

Title: AXL is a potential target for therapeutic intervention in breast cancer progression.

Journal: Cancer research 20080315

Title: Exploitation of the 3-quinolinecarbonitrile template for SRC tyrosine kinase inhibitors.

Journal: Current topics in medicinal chemistry 20080101

Title: An efficient one-pot, three-component synthesis of indeno[1,2-b]quinoline-9,11(6H,10H)-dione, acridine-1,8(2H,5H)-dione and quinoline-3-carbonitrile derivatives from enaminones.

Journal: Organic & biomolecular chemistry 20061007

Title: Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles.

Journal: Journal of medicinal chemistry 20050602

Title: Identification of 7-phenylaminothieno- [3,2-b]pyridine-6-carbonitriles as a new class of Src kinase inhibitors.

Journal: Journal of medicinal chemistry 20041230

Title: Epidermal growth factor receptor tyrosine kinase inhibitors.

Journal: British journal of cancer 20040614

Title: 4-anilino-3-quinolinecarbonitriles: an emerging class of kinase inhibitors.

Journal: Current topics in medicinal chemistry 20020901

Title: Cleavage of carbon-carbon bonds in aromatic nitriles using nickel(0).

Journal: Journal of the American Chemical Society 20020814

Title: Hydrogen bonding and dipolar interactions between quinolines and organic solvents. Nuclear magnetic resonance and ultraviolet-visible spectroscopic studies.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20010701

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 34846-64-5
Tags:34846-64-5 Molecular Formula|34846-64-5 MDL|34846-64-5 SMILES|34846-64-5 3-Quinolinecarbonitrile |Heterocyclic_Building_Blocks